	Efficacy and safety of combining radiotherapy with first-line chemotherapy and immunotherapy for local advanced/metastatic urothelial cancer: a propensity score matching analysis. Front Immunol Qin J, Zhou H, Li X, Yin H, Deng H, Luo Y, Chen Y, Yin Y, Zhou R, Zhan N, Zheng Y, Zhang T, He W. PMID: 42488678 [PubMed - indexed for MEDLINE]
	Perspective on the integration of radiomics and spatial omics in the analysis of the tumor microenvironment of bladder cancer and prospects for precision diagnosis and treatment. Front Immunol Dong Y, Su Y. PMID: 42488630 [PubMed - indexed for MEDLINE]
	Cellular plasticity and tumor ecosystem dynamics in prostate cancer: insights from single-cell and spatial transcriptomics. Am J Clin Exp Urol Watanabe R, Chu T, Miura N, Kikugawa T, Nelson PS, Saika T. PMID: 42488354 [PubMed]
	Threading the Needle in Bladder Cancer: A Narrative Review of the Emerging Role of Integrative Oncology in Treatment-Related Adverse Events in the Era of Immunotherapy and Antibody-Drug Conjugates. Cureus Niknafs AM, Damron LF, Baclig NV, Iliopoulos M, Drakaki A. PMID: 42488263 [PubMed]
	External Validation of Prognostic Models for Nonmetastatic Clear Cell Renal Cell Carcinoma in a Japanese Cohort: Evaluation of Predictive Performance. Int J Urol Nakano Y, Miyamoto S, Goto K, Yukihiro K, Tasaka S, Nomura N, Okazaki M, Shikuma H, Hatayama T, Iwane K, Tasaka R, Kohada Y, Takemoto K, Naito M, Kobatake K, Sekino Y, Kitano H, Goriki A, Hieda K, Hinata N. PMID: 42487496 [PubMed - indexed for MEDLINE]
	Prognostic value of platelet-to-lymphocyte ratio in bladder cancer: a systematic review and meta-analysis. Clin Transl Oncol Pan M, Tao T, Peng J, Zhang Y, Kong D, Chen K, Wu H, Yang B, Gong H. PMID: 42487089 [PubMed - as supplied by publisher]
	Development and internal validation of a biparametric MRI-based nomogram for predicting extraprostatic extension in patients undergoing robot-assisted radical prostatectomy. J Robot Surg Yamane H, Morizane S, Hasegawa A, Yasukawa R, Tamura J, Omatsu R, Shimizu R, Teraoka S, Nishikawa R, Kimura Y, Hikita K, Takenaka A. PMID: 42486920 [PubMed - indexed for MEDLINE]
	BCG at Home: A First-in-kind Trial of Home-based Intravesical Bacillus Calmette-GuÃ©rin Delivery for High-risk Non-muscle-invasive Bladder Cancer. Eur Urol Focus Lee DJ, Williams C, Soefje S, Flynn D, Kessler S, Northern L, Yoo J, Radovanovich A, Kim D, Cappozzi D, Obare A, Stambakio H, Guzzo T, Bivalacqua TJ. PMID: 42486771 [PubMed - as supplied by publisher]
	Re: Comprehensive Genome-wide Association Study Into Multiple Recurrence and Progression Risk in Non-muscle-invasive Bladder Cancer. Eur Urol Lazzeri M, Hurle R, Lughezzani G, Buffi NM, Casale P. PMID: 42486741 [PubMed - as supplied by publisher]
	Bleeding Events Associated With Continuing Antithrombotic Therapy During Transrectal Ultrasound-Guided Prostate Biopsy: A Propensity Score-Matched Analysis. Int J Urol Hata K, Goto Y, Hashimoto M, Okamoto M, Takahashi Y, Takiguchi Y, Saito S, Iwamoto Y, Kawaharada A, Enei Y, Sakanaka K, Takahashi K, Hisakane A, Yamazaki T, Yasue K, Aoki S, Kasai K, Ishii G, Kimura T. PMID: 42486507 [PubMed - indexed for MEDLINE]
	The Role of [(18)F]PSMA-1007 PET/CT in Staging of Prostate Cancer: influence of bone uptake and relationship with D'Amico Risk Classification. Rev Esp Med Nucl Imagen Mol (Engl Ed) Salvador MS, Eduardo VJ, Rodrigo HR, Pablo CT, Natalia RP, Anayeli LA, Ailan BP. PMID: 42486399 [PubMed - as supplied by publisher]
	Centrosome-related gene SPHK1 drives bladder cancer progression and therapeutic vulnerability. Transl Oncol Dong C, Fang Z, Han Y, Yin Y, Cao Y, Lu Q. PMID: 42485786 [PubMed - as supplied by publisher]
	Comparative efficacy of perioperative systemic therapies for muscle-invasive bladder cancer: a network meta-analysis of randomized trials. ESMO Open Maiorano BA, Maruzzo M, , Subiela JD, Soria F, Albisinni S, Mari A, Claps F, Contieri R, Gallioli A, Caño-Velasco J, D'Andrea D, Laukhtina E, Marcq G, Krajewski W, Grobet-Jeandin E, Afferi L, Del Giudice F, Rizzo A, Moschini M, Mertens LS, Cigliola A, Mercinelli C, Piacentini M, Santoni M, Pradère B, Necchi A, Young Academic Urologist (YAU) Urothelial Carcinoma Working Group. PMID: 42485700 [PubMed - as supplied by publisher]
	Enfortumab Vedotin and Pembrolizumab in Cisplatin-Eligible Bladder Cancer. N Engl J Med Galsky MD, Valderrama BP, Maruzzo M, Font A, Ciuleanu T, Chatzkel J, Koie T, Hoimes CJ, Puente J, Zakharia Y, Rosenbaum E, Boehm K, Loriot Y, Bedke J, Powles TB, Necchi A, Wiechno P, Álvarez-Fernández C, Kim TH, Oliveira N, Flaig TW, Wirtz HS, Mihm M, Huang Q, Rogiers A, Homet Moreno B, Gómez de Liaño A, KEYNOTE-B15/EV-304 Investigators. PMID: 42485627 [PubMed - indexed for MEDLINE]
	A phase I dose-escalation/expansion study of fractionated-dose and multiple cycle anti-PSMA-targeted alpha emitter 225Ac-J591 in patients with prostate cancer. Clin Cancer Res Tagawa ST, Thomas C, Arham AB, Holmes A, Marulanda Corzo V, Okobi T, Vallabhajosula S, Avlonitis V, Huicochea Castellanos S, Nauseef JT, O'Dwyer E, Fatima M, Gregos P, Yuan S, Sternberg CN, Molina A, Nanus DM, Bander NH, Osborne J. PMID: 42485097 [PubMed - as supplied by publisher]
	An Integrated Cell-Death Program Defines Aggressive Prostate Cancer by Coupling Ezrin to the Hippo-YAP/TAZ Axis. Ann Surg Oncol Luo X, Huang Z, Deng M, Liu J, Liao C, Yang Y, Meng Z, Yuan J, Xu J, Liu Y, Wang Q, Wang Z, Li H, Shi R, Zeng H, Su S, Liu L, Zheng J. PMID: 42484820 [PubMed - as supplied by publisher]
	Efficacy and safety of immunotherapy-based combination therapy as first-line treatment for advanced renal cell carcinoma: a systematic review and network meta-analysis. Med Oncol Ou X, Li Y, Zhan M, Tao T, Chen P. PMID: 42484760 [PubMed - indexed for MEDLINE]
	Sarcomatoid Carcinoma of the Prostate With Both Chondrosarcomatous and Osteosarcomatous Differentiation Following Androgen Deprivation Therapy: A Case Report and Diagnostic Considerations. Int J Surg Pathol Akbas P, Bektas S, Gelmis M, Berker F. PMID: 42484555 [PubMed - as supplied by publisher]
	Effects of Modifying Hinotori Surgical Robot System on the Learning Curve of Robot-Assisted Radical Prostatectomy. Int J Urol Mita Y, Teishima J, Ueki H, Wakita N, Okamura Y, Suzuki K, Bando Y, Hara T, Terakawa T, Chiba K, Miyake H. PMID: 42484052 [PubMed - indexed for MEDLINE]
	Artificial Intelligence Versus Conventional Methods for NCCN Risk Stratification in Localized Prostate Cancer (2020-2025): A Systematic Review. Prostate Cancer Hassan WA, Meligy OAE, Talaat IM. PMID: 42483695 [PubMed]

Articles 1 - 20 / 180235

Page 1 of 9012



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy